Src - Rous sarcoma oncogene Gene

Mus musculus

Also known as pp60c-src

Gene ID: 20779 | Gene type: protein coding

About Src

Chromosome 2: 157,260,364-157,313,782 forward strand.GRCm39:CM000995.3

This gene has 8 transcripts (splice variants), 261 orthologues, 32 paralogues and is associated with 54 phenotypes. Ubiquitous expression in duodenum adult (RPKM 49.), colon adult (RPKM 48.4) and 23 other tissues.

Summary

Enables several functions, including connexin binding activity; Ephrin Receptor binding activity; and scaffold protein binding activity. Involved in several processes, including interleukin-6-mediated signaling pathway; positive regulation of signal transduction; and protein destabilization. Acts upstream of or within several processes, including animal organ development; cellular response to growth factor stimulus; and regulation of signal transduction. Located in several cellular components, including actin cytoskeleton; focal adhesion; and ruffle membrane. Is expressed in several structures, including central nervous system; early conceptus; genitourinary system; gut; and retina. Used to study Williams-Beuren syndrome. Human ortholog(s) of this gene implicated in colorectal Cancer (multiple); ductal carcinoma in situ; prostate cancer; thrombocytopenia; and type 2 diabetes mellitus. Orthologous to human Src (Src proto-oncogene, non-receptor tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]

Src Products(13)

mRNA	Protein	Name
NM_001412690.1	NP_001399619.1	proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412691.1	NP_001399620.1	proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001025395.3	NP_001020566.1	proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412689.1	NP_001399618.1	proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412693.1	NP_001399622.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412682.1	NP_001399611.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412683.1	NP_001399612.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_009271.4	NP_033297.2	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412687.1	NP_001399616.1	proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412686.1	NP_001399615.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412684.1	NP_001399613.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412685.1	NP_001399614.1	proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412688.1	NP_001399617.1	proto-oncogene tyrosine-protein kinase Src isoform 2

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	Reference	Source
enables connexin binding	IPI IPI: Inferred from physical interaction	14699011	MGI
enables ephrin receptor binding	IPI IPI: Inferred from physical interaction	12925710	MGI
enables kinase activity	IMP IMP: Inferred from mutant phenotype	12808090	MGI
enables protein binding	IPI IPI: Inferred from physical interaction	7518772	MGI
enables protein domain specific binding	IPI IPI: Inferred from physical interaction	8438166	MGI
enables protein kinase activity	IDA IDA: Inferred from direct assay	11274221	MGI
enables protein kinase activity	IMP IMP: Inferred from mutant phenotype	23100514	MGI
enables protein tyrosine kinase activity	EXP EXP: Inferred from Experiment	22759635	MGI
enables protein tyrosine kinase activity	IDA IDA: Inferred from direct assay	8910389	MGI
enables protein tyrosine kinase activity	IMP IMP: Inferred from mutant phenotype	12091389	MGI
enables scaffold protein binding	IPI IPI: Inferred from physical interaction	12091389	MGI

Biological Process GO Annotation	Evidence	Reference	Source
involved in angiotensin-activated signaling pathway	IGI IGI: Inferred from genetic interaction	25017399	MGI
acts upstream of or within bone resorption	IMP IMP: Inferred from mutant phenotype	19448635	MGI
involved in bone resorption	IMP IMP: Inferred from mutant phenotype	14739300	MGI
acts upstream of or within branching involved in mammary gland duct morphogenesis	IMP IMP: Inferred from mutant phenotype	16007215	MGI
acts upstream of or within cell migration	IMP IMP: Inferred from mutant phenotype	15292044	MGI
acts upstream of or within cellular response to fluid shear stress	IMP IMP: Inferred from mutant phenotype	24841674	MGI
acts upstream of or within cellular response to hydrogen peroxide	IMP IMP: Inferred from mutant phenotype	23651497	MGI
involved in cellular response to peptide hormone stimulus	IGI IGI: Inferred from genetic interaction	25017399	MGI
acts upstream of or within cellular response to platelet-derived growth factor stimulus	IDA IDA: Inferred from direct assay	17623777	MGI
acts upstream of or within cellular response to reactive oxygen species	IDA IDA: Inferred from direct assay	24190966	MGI
acts upstream of or within cellular response to transforming growth factor beta stimulus	IGI IGI: Inferred from genetic interaction	21829547	MGI
acts upstream of or within forebrain development	IGI IGI: Inferred from genetic interaction	16162939	MGI
involved in interleukin-6-mediated signaling pathway	IDA IDA: Inferred from direct assay	25731159	MGI
involved in intestinal epithelial cell development	IDA IDA: Inferred from direct assay	25731159	MGI
acts upstream of or within intracellular signal transduction	IGI IGI: Inferred from genetic interaction	23526378	MGI
acts upstream of or within odontogenesis	IMP IMP: Inferred from mutant phenotype	23174213	MGI
acts upstream of or within oogenesis	IMP IMP: Inferred from mutant phenotype	16007215	MGI
acts upstream of or within osteoclast development	IGI IGI: Inferred from genetic interaction	23526378	MGI
acts upstream of or within peptidyl-tyrosine phosphorylation	IDA IDA: Inferred from direct assay	12526740	MGI
involved in peptidyl-tyrosine phosphorylation	IMP IMP: Inferred from mutant phenotype	27505886	MGI
involved in phosphorylation	IMP IMP: Inferred from mutant phenotype	12091389	MGI
involved in positive regulation of ERK1 and ERK2 cascade	IMP IMP: Inferred from mutant phenotype	17045821	MGI
involved in positive regulation of Notch signaling pathway	IDA IDA: Inferred from direct assay	25731159	MGI
acts upstream of or within positive regulation of canonical Wnt signaling pathway	IGI IGI: Inferred from genetic interaction	19920076	MGI
involved in positive regulation of glycolytic process	IDA IDA: Inferred from direct assay	35263589	MGI
acts upstream of or within positive regulation of peptidyl-tyrosine phosphorylation	IGI IGI: Inferred from genetic interaction	17344476	MGI
acts upstream of or within positive regulation of platelet-derived growth factor receptor-beta signaling pathway	IMP IMP: Inferred from mutant phenotype	23651497	MGI
acts upstream of or within positive regulation of podosome assembly	IDA IDA: Inferred from direct assay	21525037	MGI
acts upstream of or within positive regulation of podosome assembly	IGI IGI: Inferred from genetic interaction	21525037	MGI
acts upstream of or within positive regulation of protein localization to nucleus	IGI IGI: Inferred from genetic interaction	17344476	MGI
acts upstream of or within positive regulation of protein processing	IGI IGI: Inferred from genetic interaction	17344476	MGI
involved in protein destabilization	IMP IMP: Inferred from mutant phenotype	25259869	MGI
acts upstream of or within protein phosphorylation	IDA IDA: Inferred from direct assay	11274221	MGI
acts upstream of or within regulation of cell projection assembly	IGI IGI: Inferred from genetic interaction	11864995	MGI
involved in regulation of heart rate by cardiac conduction	IGI IGI: Inferred from genetic interaction	25017399	MGI
acts upstream of or within regulation of intracellular estrogen receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	16007215	MGI
acts upstream of or within regulation of protein binding	IDA IDA: Inferred from direct assay	22027834	MGI
acts upstream of or within substrate adhesion-dependent cell spreading	IDA IDA: Inferred from direct assay	11864995	MGI
acts upstream of or within uterus development	IMP IMP: Inferred from mutant phenotype	16007215	MGI

Cellular Component GO Annotation	Evidence	Reference	Source
located in actin filament	IDA IDA: Inferred from direct assay	17623777	MGI
located in caveola	IDA IDA: Inferred from direct assay	12091389	MGI
located in cytoplasm	IDA IDA: Inferred from direct assay	14699011	MGI
located in cytoskeleton	IDA IDA: Inferred from direct assay	12615910	MGI
located in focal adhesion	IMP IMP: Inferred from mutant phenotype	22801373	MGI
located in membrane	IMP IMP: Inferred from mutant phenotype	22801373	MGI
located in mitochondrial inner membrane	IDA IDA: Inferred from direct assay	12615910	MGI
located in mitochondrion	IDA IDA: Inferred from direct assay	12615910	MGI
located in nucleus	IDA IDA: Inferred from direct assay	12615910	MGI
located in perinuclear region of cytoplasm	IDA IDA: Inferred from direct assay	17623777	MGI
located in plasma membrane	IDA IDA: Inferred from direct assay	12615910	MGI
located in podosome	IDA IDA: Inferred from direct assay	17893324	MGI
located in ruffle membrane	IDA IDA: Inferred from direct assay	17623777	MGI

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Src Protein Structure

SH3_Src

SH2_Src_Src

PTKc_Src

0
100
200
300
400
500
535 a.a.

Protein Preferred Names

Protein Names

proto-oncogene tyrosine-protein kinase Src

neuronal proto-oncogene tyrosine-protein kinase Src

p60-Src

proto-oncogene c-Src

Recombinant Src Proteins

Cat. No.	Product Name	Accession	Purity
HY-P73423	Src Protein, Mouse (sf9, His-GST)	P05480-2 (M1-L535)	≥95%

Related Agents

Approval

Bioactive Molecules (10)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10181	Dasatinib	Inhibitor	99.85%	Yes
HY-12047	Ponatinib	Inhibitor	99.67%	Yes
HY-10158	Bosutinib	Inhibitor	99.96%	Yes
HY-10209	Masitinib	Inhibitor	99.98%	Yes
HY-10181A	Dasatinib hydrochloride	Inhibitor	99.67%	Yes
HY-108766	Ponatinib hydrochloride	Inhibitor	99.55%	Yes
HY-10209A	Masitinib mesylate	Inhibitor	99.51%	Yes
HY-10340B	Tirbanibulin Mesylate	Inhibitor	99.94%	Unkown
HY-10181B	Dasatinib monohydrate	Inhibitor	98.48%	Yes
HY-10158A	Bosutinib hydrate	Inhibitor	99.97%	Yes

Clinical Phase

Bioactive Molecules (17)

Cat. No.	Product Name	Effect	Purity	Phase
HY-10234	Saracatinib	Inhibitor	99.92%	Phase 3
HY-10340	Tirbanibulin	Inhibitor	99.45%	Phase 3
HY-13314	Tesevatinib	Inhibitor	99.21%	Phase 3
HY-10340A	Tirbanibulin dihydrochloride	Inhibitor	99.59%	Phase 3
HY-13024	Rebastinib	Inhibitor	99.91%	Phase 2
HY-50868	Bafetinib	Inhibitor	99.77%	Phase 2
HY-15323	PRT062607 Hydrochloride	Inhibitor	98.07%	Phase 2
HY-32718	Pelitinib	Inhibitor	99.13%	Phase 2
HY-59047	Tolimidone	Activator	99.93%	Phase 2
HY-111787	Elzovantinib	Inhibitor	99.93%	Phase 2
HY-10987A	ENMD-2076	Inhibitor	99.12%	Phase 2
HY-10186	TG 100801	Inhibitor	98.61%	Phase 2
HY-10987	ENMD-2076 Tartrate	Inhibitor	99.42%	Phase 2
HY-10187	TG 100801 Hydrochloride	Inhibitor	/	Phase 2
HY-15749	XL228	Inhibitor	99.64%	Phase 1
HY-112809	GSK2646264	Inhibitor	98.39%	Phase 1
HY-112314	AZD0424	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (171)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-13805	PP2	Inhibitor	98.34%	Unkown
HY-12299	WH-4-023	Inhibitor	99.75%	Unkown
HY-N0752	Scutellarein	Inhibitor	99.25%	Unkown
HY-B0789	SU6656	Inhibitor	99.01%	Unkown
HY-112096	eCF506	Inhibitor	99.77%	Unkown
HY-12072	Lck Inhibitor	Inhibitor	99.45%	Unkown
HY-101053	Src Inhibitor 1	Inhibitor	99.93%	Unkown
HY-N0031	Plantamajoside		99.52%	Unkown
HY-15764A	A 419259 trihydrochloride	Inhibitor	99.21%	Unkown
HY-13804	PP1	Inhibitor	99.00%	Unkown
HY-136848	SM1-71	Inhibitor	96.09%	Unkown
HY-W062835	CGP77675	Inhibitor	99.00%	Unkown
HY-130254	CSK-IN-1	Inhibitor	98.61%	Unkown
HY-135299	CH6953755	Inhibitor	99.45%	Unkown
HY-13942	1-NM-PP1	Inhibitor	99.17%	Unkown
HY-11011	A-770041	Inhibitor	99.95%	Unkown
HY-10032	PF 477736	Inhibitor	99.21%	Unkown
HY-13941	1-Naphthyl PP1	Inhibitor	99.08%	Unkown
HY-15764	A 419259	Inhibitor	99.75%	Unkown
HY-112852	TL02-59	Inhibitor	99.84%	Unkown
HY-139147	iHCK-37	Inhibitor	99.52%	Unkown
HY-10395	PD173955	Inhibitor	99.12%	Unkown
HY-18303	AMG-47a	Inhibitor	99.34%	Unkown
HY-N0202	Atractylenolide II	Inhibitor	99.94%	Unkown
HY-108318	RK-24466	Inhibitor	98.53%	Unkown
HY-112182	UM-164	Inhibitor	99.15%	Unkown
HY-10372	PP121	Inhibitor	98.67%	Unkown
HY-155657	BT424	Inhibitor	98.81%	Unkown
HY-78263	MNS	Inhibitor	99.55%	Unkown
HY-132166	M4205	Inhibitor	99.47%	Unkown
HY-P3279	EPQpYEEIPIYL	Activator	99.62%	Unkown
HY-122113	PD173952	Inhibitor	99.44%	Unkown
HY-101795	Larixyl acetate	Inhibitor	99.46%	Unkown
HY-13561	AZM475271	Inhibitor	99.85%	Unkown
HY-18622	PP58	Inhibitor	99.75%	Unkown
HY-136605	DGY-06-116	Inhibitor	99.54%	Unkown
HY-101963	AD80	Inhibitor	99.88%	Unkown
HY-10644	Lck inhibitor 2	Inhibitor	99.73%	Unkown
HY-108488	KB SRC 4	Inhibitor	99.66%	Unkown
HY-118144	PD166326	Inhibitor	99.99%	Unkown
HY-163144	DAS-5-oCRBN	Degrader	98.75%	Unkown
HY-120213	YH-306	Inhibitor	98.34%	Unkown
HY-100434	PD-161570	Inhibitor	99.82%	Unkown
HY-146127A	Grb2 SH2 domain inhibitor 1 TFA	Inhibitor	99.71%	Unkown
HY-159480	AD1058	Inhibitor	98.11%	Unkown
HY-10185	TG 100572 Hydrochloride	Inhibitor	98.96%	Unkown
HY-103274	PD180970	Inhibitor	99.27%	Unkown
HY-N4127	3'-Demethylnobiletin		99.98%	Unkown
HY-107024	Osteogenic Growth Peptide (10-14)	Inhibitor	99.77%	Unkown
HY-P1377A	Caffeic acid-pYEEIE TFA		98.47%	Unkown
HY-127002	Squarunkin A	Inhibitor	99.34%	Unkown
HY-108485	Damnacanthal	Inhibitor	≥98.0%	Unkown
HY-13941B	1-Naphthyl PP1 hydrochloride	Inhibitor	99.83%	Unkown
HY-15805	KIN-8194	Inhibitor	98.01%	Unkown
HY-10181S	Dasatinib-d8	Inhibitor	98.17%	Unkown
HY-155582	BLK degrader 1	Degrader	98.92%	Unkown
HY-153556	GW297361	Inhibitor	98.13%	Unkown
HY-18623	VI 16832	Ligand	98.82%	Unkown
HY-120595	JNJ-49095397	Inhibitor	99.85%	Unkown
HY-N4201	β-Hydroxyisovalerylshikonin	Inhibitor	99.83%	Unkown
HY-112345	PD-089828	Inhibitor	98.07%	Unkown
HY-108016	Peruvoside	Inhibitor	99.32%	Unkown
HY-18237	KX1-004	Inhibitor	99.75%	Unkown
HY-10234A	Saracatinib difumarate	Inhibitor	99.24%	Yes
HY-132150A	HPK1-IN-2 dihydrochloride	Inhibitor	98.69%	Unkown
HY-15324	PRT062607 acetate	Inhibitor	99.83%	Unkown
HY-15814	HG-7-85-01	Inhibitor	99.94%	Unkown
HY-W744699	Larixol	Inhibitor	95.52%	Unkown
HY-123506	Fenlean	Inhibitor	99.56%	Unkown
HY-125028	Hck-IN-1	Inhibitor	98.53%	Unkown
HY-W013857	Lavendustin C	Inhibitor	98.32%	Unkown
HY-112291	SB 220025	Inhibitor	99.90%	Unkown
HY-136849	TL13-68	Inhibitor	98.88%	Unkown
HY-15764G	A 419259 (GMP)	Inhibitor	/	Unkown
HY-116028	15-deoxy-Δ12,14-Prostaglandin D2	Activator	≥98.0%	Unkown
HY-N6596	7-Hydroxy-4H-chromen-4-one	Inhibitor	99.94%	Unkown
HY-10158S	Bosutinib-d8	Inhibitor	≥99.0%	Unkown
HY-12047S	Ponatinib-d8	Inhibitor	99.91%	Unkown
HY-138202	Lck-IN-1	Inhibitor	99.6%	Unkown
HY-111187	KX2-361	Inhibitor	99.55%	Unkown
HY-155587	Hydroxy-PP	Inhibitor	99.66%	Unkown
HY-13342AS	Apatinib-d8 free base		92.56%	Unkown
HY-163469	SRC-3-IN-2	Inhibitor	/	Unkown
HY-18507	AD57	Inhibitor	98.08%	Unkown
HY-16905	T338C Src-IN-1	Inhibitor	/	Unkown
HY-10184	TG 100572	Inhibitor	/	Unkown
HY-N7160	2-Hydroxy-3-methylanthraquinone	Inhibitor	99.60%	Unkown
HY-16906	T338C Src-IN-2	Inhibitor	/	Unkown
HY-118105	RK-20448	Inhibitor	99.38%	Unkown
HY-112852A	TL02-59 dihydrochloride	Inhibitor	/	Unkown
HY-157998	mG2N001		/	Unkown
HY-156914	IGF-1R/SRC-IN-1	Inhibitor	99.86%	Unkown
HY-P10372	pFYN peptide		/	Unkown
HY-12847	CCT241161	Inhibitor	/	Unkown
HY-P1111	Lyn peptide inhibitor	Inhibitor	/	Unkown
HY-123298	Chrysotoxine	Inhibitor	/	Unkown
HY-157290	HL403	Inhibitor	/	Unkown
HY-101447	SI-2	Inhibitor	/	Unkown
HY-115723	Antiallergic agent-1	Inhibitor	/	Unkown
HY-110367A	LCB 03-0110	Inhibitor	/	Unkown
HY-W745090	Isomaltulose monohydrate	Inhibitor	/	Unkown
HY-149921	Antiangiogenic agent 3	Inhibitor	/	Unkown
HY-101268	CHMFL-ABL-053	Inhibitor	/	Unkown
HY-110367	LCB 03-0110 dihydrochloride	Inhibitor	/	Unkown
HY-162879	FAK inhibitor 7	Inhibitor	/	Unkown
HY-W062835A	CGP77675 hydrate	Inhibitor	/	Unkown
HY-P0200	RR-SRC		/	Unkown
HY-168901	Hck-IN-2	Inhibitor	/	Unkown
HY-170958	Scr-IN-1	Inhibitor	/	Unkown
HY-112096S	eCF506-d5	Inhibitor	/	Unkown
HY-150026	Multi-kinase-IN-2	Inhibitor	/	Unkown
HY-170971	Src Inhibitor 4	Inhibitor	/	Unkown
HY-135216	Antiproliferative agent-54	Inhibitor	/	Unkown
HY-10363	AP 24149	Inhibitor	/	Unkown
HY-162291	Lck-IN-3	Inhibitor	/	Unkown
HY-P2372	P60v-src(137-157)	Inhibitor	/	Unkown
HY-112335	Lck Inhibitor III	Inhibitor	/	Unkown
HY-137918	TGF-βRI inhibitor 3	Inhibitor	/	Unkown
HY-15268	PP487	Inhibitor	/	Unkown
HY-162676	SJ45566	Degrader	/	Unkown
HY-P1200	Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH	Inhibitor	/	Unkown
HY-168187	Src Inhibitor 3	Inhibitor	/	Unkown
HY-102073	TG53	Inhibitor	/	Unkown
HY-121828	TX-1123	Inhibitor	/	Unkown
HY-147314	HIV-IN-6		98.35%	Unkown
HY-P10665	pYEEI	Inhibitor	/	Unkown
HY-121849	KL-1156	Inhibitor	/	Unkown
HY-P10527	CSK substrate		/	Unkown
HY-P3773	p60c-src substrate II		/	Unkown
HY-P3743	p60c-src Substrate		/	Unkown
HY-18507A	AD57 hydrochloride	Inhibitor	/	Unkown
HY-13314A	Tesevatinib tosylate	Inhibitor	/	Unkown
HY-128397	CpCDPK1/TgCDPK1-IN-1	Inhibitor	/	Unkown
HY-136699	Excisanin A	Inhibitor	/	Unkown
HY-168893	K882	Inhibitor	/	Unkown
HY-100824	PP2 Analog	Inhibitor	/	Unkown
HY-P1111A	Lyn peptide inhibitor TFA	Inhibitor	/	Unkown
HY-P1377	Caffeic acid-pYEEIE		/	Unkown
HY-162413	(R)-LW-Srci-8	Inhibitor	/	Unkown
HY-146014	Multi-kinase-IN-1	Inhibitor	/	Unkown
HY-P2547	Tyrosine Kinase Peptide 1		/	Unkown
HY-P2413	Ac-PPPHPHARIK-NH2	Inhibitor	/	Unkown
HY-112393	TX-1918	Inhibitor	/	Unkown
HY-163468	SRC-3-IN-1	Inhibitor	/	Unkown
HY-P3771	p60c-src substrate II, phosphorylated		/	Unkown
HY-10181G	Dasatinib (GMP)	Inhibitor	/	Unkown
HY-139890	DC-Srci-6649	Inhibitor	/	Unkown
HY-127002A	Squarunkin A hydrochloride	Inhibitor	/	Unkown
HY-157497	DA5-HTL	Inhibitor	/	Unkown
HY-172096	cSRC/BCR-ABL-IN-1	Inhibitor	/	Unkown
HY-P1200A	Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA	Inhibitor	/	Unkown
HY-161687	Cisplatin/Dasatinib prodrug-1	Inhibitor	/	Unkown
HY-125387	TOP1210		/	Unkown
HY-163278	Lck-IN-2	Inhibitor	/	Unkown
HY-10181S1	Dasatinib-d4	Inhibitor	/	Unkown
HY-122585	proMMP-9 inhibitor-3c	Inhibitor	/	Unkown
HY-W994722	ISO24	Ligand	/	Unkown
HY-N12166	2,3,4,6,8-Pentahydroxy-1-methylxanthone	Inhibitor	/	Unkown
HY-171217	TG-100435	Inhibitor	/	Unkown
HY-125064	AP22408	Inhibitor	/	Unkown
HY-112291A	SB 220025 (tri(hydrochloride))	Inhibitor	/	Unkown
HY-W700620	Hydroxymethyl dasatinib	Inhibitor	99.92%	Unkown
HY-10234S	Saracatinib-d3	Inhibitor	/	Unkown
HY-136622	A-420983	Inhibitor	/	Unkown
HY-120622	BMS-243117	Inhibitor	/	Unkown
HY-160930	TOP1288	Inhibitor	/	Unkown
HY-164530	SKLB646	Inhibitor	/	Unkown
HY-10158AR	Bosutinib (hydrate) (Standard)	Inhibitor	/	Unkown
HY-171218	CGP062464	Inhibitor	/	Unkown
HY-164527	Si306	Inhibitor	/	Unkown
HY-169670	Protein kinase inhibitor 13	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Src	NCBI	NCBI:6714

Name
Email *

	Sorry, but the email address you supplied was invalid.